Oncology Based In-vivo CRO Market Report 2022 | Share, Trends 2027

Oncology Based In-vivo CRO Market Report 2022 | Share, Trends 2027
Oncology Based In-vivo CRO Market Report 2022-2027
The global oncology based in-vivo CRO market reached a value of US$ 1.05 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 1.69 Billion by 2027, exhibiting a growth rate (CAGR) of 7.81% during 2022-2027.

The latest research study “Oncology Based In-vivo CRO Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global oncology based in-vivo CRO market size reached a value of US$ 1.05 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 1.69 Billion by 2027, exhibiting a CAGR of 7.81% during 2022-2027.

What is Oncology Based In-vivo CRO?

Oncology refers to a branch of medicine that deals with the study, diagnosis, and treatment of cancer using ultrasound, positron emission tomography (PET) scanning, magnetic resonance imaging (MRI), computed tomography (CT) scanning, biopsy, endoscopy, and X-ray. It helps patients tolerate and ease cancer side effects by offering immunotherapy, radiotherapy, hormonal therapy, and oral therapies. At present, oncology based in-vivo CRO is gaining immense traction globally due to the development of several investigational compounds for treating cancer by contract research organizations (CROs).

Request a PDF Sample for more detailed market insights: https://www.imarcgroup.com/oncology-based-in-vivo-cro-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Oncology Based In-Vivo CRO Market Trends and Drivers:

The global oncology based in-vivo CRO market is primarily driven by the rising prevalence of cancer among individuals. Moreover, there is a rise in genetic engineering innovations for altering the characteristics of organisms and manipulating deoxyribonucleic acid (DNA). In line with this, the improving focus on the study of oncogene to regulate the growth, proliferation, and differentiation of cells has catalyzed the market growth.

Besides this, governments of several countries are investing in research and development (R&D) activities. This, along with the increasing expertise of contract research organizations (CROs) in cancer treatment, is driving market growth. Furthermore, the easy availability of medications and the expanding healthcare industry are other major growth-inducing factors.

Other factors, including the surging adoption of telehealth and virtual clinical trials in the healthcare sector, rising usage of generics, and high failure rate of existing treatment options, are also anticipated to create a favorable market outlook.

Oncology Based In-Vivo CRO Market Report Scope

Report Coverage


Market size value in 2021

US$ 1.05 Billion

Market forecast in 2027

US$ 1.69 Billion

Growth Rate

CAGR of 7.81% from 2022 to 2027

Base year for estimation


Historical data


Forecast period


Global Oncology Based In-Vivo CRO Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Oncology Based In-Vivo CRO Companies:

Champions Oncology Inc. (NASDAQ: CSBR)

Charles River Laboratories International Inc. (NYSE: CRL)

Crown Bioscience Inc.

Eurofins Scientific (OTCMKTS: ERFSF)



Labcorp Drug Development (Laboratory Corporation of America Holdings)

Living Tumor Laboratory

Taconic Biosciences Inc.

The Jackson Laboratory

WuXi AppTec and Xentech

Explore Report Description with TOC & List of Figure: https://www.imarcgroup.com/oncology-based-in-vivo-cro-market

The report has segmented the market on the basis of region, indication, model and application.

Breakup by Indication:

  • Blood Cancer
  • Solid Tumors
  • Others  

Breakup by Model:

  • Syngeneic
  • Xenograft
  • Patient Derived Xenograft (PDX)
  • Others  

Breakup by Application:

  • Hospitals
  • Rehabilitation Centers

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022- 2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Browse More Trending Industry Research Reports (Book Now With 10% Discount + COVID-19 Scenario):

Rigid Plastic Packaging Market By Product, Material, Production Process, End Use Industry, Global Opportunity Analysis and Industry Forecast, 2022-2027

India Electric Vehicle Market By Vehicle Type, Price Category, Propulsion Type, Opportunity Analysis and Industry Forecast, 2022-2027

High-performance Computing (HPC) Market By Component, Deployment Type, End Use, Global Opportunity Analysis and Industry Forecast, 2022-2027

Radiology Information System Market By Type, Component, Deployment Mode, End User, Global Opportunity Analysis and Industry Forecast, 2022-2027

Unified Communications Market By Component, Product, Organization Size, End User, Global Opportunity Analysis and Industry Forecast, 2022-2027

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: Send Email
Phone: +1-631-791-1145
Address:30 N Gould St Ste R
City: Sheridan
State: WY
Country: United States
Website: https://www.imarcgroup.com